Explore expert-vetted resources on diseases of mind and sight.
What AREDS2 eye vitamins do, who should take them, and what the research says about slowing macular degeneration.
Meet Fred Jacobson, a dedicated support of Macular Degeneration Research.
In this timely discussion, Dr. Suzanne Schindler will explain how blood-based biomarkers are transforming Alzheimer’s diagnosis, research, and care.
Dr. Karl Wahlin explores how regenerative medicine and retinal cell replacement strategies could transform the future of glaucoma treatment and vision preservation.
Dr. Gil Rabinovici explores trontinemab, an investigational next-generation anti-amyloid therapy being studied for early Alzheimer’s disease.
Dr. April McCullough of Regeneron and Katherine Freund of Independent Transportation Network of America discuss the real-world barriers that prevent people with vision loss from accessing timely eye care and solutions that are available.